These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 26696518)

  • 1. Human pluripotent stem cell based islet models for diabetes research.
    Balboa D; Otonkoski T
    Best Pract Res Clin Endocrinol Metab; 2015 Dec; 29(6):899-909. PubMed ID: 26696518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of insulin-producing cells from pluripotent stem cells: from the selection of cell sources to the optimization of protocols.
    Liew CG
    Rev Diabet Stud; 2010; 7(2):82-92. PubMed ID: 21060967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The state of the art of islet transplantation and cell therapy in type 1 diabetes.
    Pellegrini S; Cantarelli E; Sordi V; Nano R; Piemonti L
    Acta Diabetol; 2016 Oct; 53(5):683-91. PubMed ID: 26923700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Making β cells from adult tissues.
    Efrat S; Russ HA
    Trends Endocrinol Metab; 2012 Jun; 23(6):278-85. PubMed ID: 22537825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An arduous journey from human pluripotent stem cells to functional pancreatic β cells.
    Loo LSW; Lau HH; Jasmen JB; Lim CS; Teo AKK
    Diabetes Obes Metab; 2018 Jan; 20(1):3-13. PubMed ID: 28474496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Differentiation of Pluripotent Stem Cells into Functional β Islets Under 2D and 3D Culture Conditions and In Vivo Preclinical Validation of 3D Islets.
    Bose B; Sudheer PS
    Methods Mol Biol; 2016; 1341():257-84. PubMed ID: 25783769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pluripotent stem cell-derived pancreatic β-cells: potential for regenerative medicine in diabetes.
    Kao DI; Chen S
    Regen Med; 2012 Jul; 7(4):583-93. PubMed ID: 22817630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling different types of diabetes using human pluripotent stem cells.
    Abdelalim EM
    Cell Mol Life Sci; 2021 Mar; 78(6):2459-2483. PubMed ID: 33242105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of human pluripotent stem cell-derived pancreatic β-like cells in the mouse pancreas.
    Ma H; Wert KJ; Shvartsman D; Melton DA; Jaenisch R
    Proc Natl Acad Sci U S A; 2018 Apr; 115(15):3924-3929. PubMed ID: 29599125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances and potential applications of human pluripotent stem cell-derived pancreatic β cells.
    Zhou Z; Ma X; Zhu S
    Acta Biochim Biophys Sin (Shanghai); 2020 Jul; 52(7):708-715. PubMed ID: 32445468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of human pluripotent stem cells into β-cells: Potential and challenges.
    Quiskamp N; Bruin JE; Kieffer TJ
    Best Pract Res Clin Endocrinol Metab; 2015 Dec; 29(6):833-47. PubMed ID: 26696513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Pluripotent Stem Cells to Model Islet Defects in Diabetes.
    Balboa D; Iworima DG; Kieffer TJ
    Front Endocrinol (Lausanne); 2021; 12():642152. PubMed ID: 33828531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the Generation of Functional β-cells from Induced Pluripotent Stem Cells As a Cure for Diabetes Mellitus.
    Kalra K; Chandrabose ST; Ramasamy TS; Kasim NHBA
    Curr Drug Targets; 2018; 19(13):1463-1477. PubMed ID: 29874998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro generation of pancreatic β-cells for diabetes treatment. I. β-like cells derived from human pluripotent stem cells.
    Cierpka-Kmiec K; Wronska A; Kmiec Z
    Folia Histochem Cytobiol; 2019; 57(1):1-14. PubMed ID: 30869153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Signals guiding differentiation of pluripotent stem cells into pancreatic beta cells].
    Kume S
    Nihon Yakurigaku Zasshi; 2014 Jul; 144(1):8-12. PubMed ID: 25007805
    [No Abstract]   [Full Text] [Related]  

  • 16. Co-culture with mature islet cells augments the differentiation of insulin-producing cells from pluripotent stem cells.
    Oh BJ; Oh SH; Choi JM; Jin SM; Shim WY; Lee MS; Lee MK; Kim KW; Kim JH
    Stem Cell Rev Rep; 2015 Feb; 11(1):62-74. PubMed ID: 25173880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replacing and safeguarding pancreatic β cells for diabetes.
    Bruin JE; Rezania A; Kieffer TJ
    Sci Transl Med; 2015 Dec; 7(316):316ps23. PubMed ID: 26631630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical strategies for pancreatic β cell differentiation, reprogramming, and regeneration.
    Ma X; Zhu S
    Acta Biochim Biophys Sin (Shanghai); 2017 Apr; 49(4):289-301. PubMed ID: 28338772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in generation of human surrogate β cells.
    Efrat S
    Curr Opin Endocrinol Diabetes Obes; 2013 Aug; 20(4):259-64. PubMed ID: 23807600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons from Human Islet Transplantation Inform Stem Cell-Based Approaches in the Treatment of Diabetes.
    Triolo TM; Bellin MD
    Front Endocrinol (Lausanne); 2021; 12():636824. PubMed ID: 33776933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.